Zhitong Finance App News, China Biopharmaceuticals (01177.HK) announced that the Group has signed a strategic option and licensing agreement (agreement) with Boehringer Ingelheim. This is the second cooperation between the two sides in the field of oncology. The two sides are committed to jointly establishing a long-term strategic partnership.

Zhitongcaijing · 22h ago
Zhitong Finance App News, China Biopharmaceuticals (01177.HK) announced that the Group has signed a strategic option and licensing agreement (agreement) with Boehringer Ingelheim. This is the second cooperation between the two sides in the field of oncology. The two sides are committed to jointly establishing a long-term strategic partnership.